Dr. FATIMA Sarwat
Education
B.Sc (Hons), The Hong Kong Polytechnic University, 2003
M.Phil., The Hong Kong Polytechnic University, 2005
Ph.D., The University of Hong Kong, 2011
Discipline
Molecular biology
Book Chapters

Kenneth K. Lai, Kin-Tak Chan, Sarwat Fatima, Nikki P. Lee, Simon Law. In: New Advances on
Disease Biomarkers and Molecular Targets in Cancer and Biomedicine. Springer Publishers,
2012. (invited book chapter).

Felix H. Shek, Tracy C.W. Lai, Sarwat Fatima, Nikki P. Lee. In: New Advances on Disease
Biomarkers and Molecular Targets in Cancer and Biomedicine. Springer Publishers,
2012. (invited book chapter).

Luk JM, Fatima S, Lee NP, Fan ST. Liver cancer biomarkers. In: Dan Hellberg (Ed.),Textbook Histological and serological tumor markers and their clinical usefulness in cancer. Nova
Publishers Inc, New York, USA, 2008. (invited textbook chapter)
Publication

Shek FH, Fatima S, Lee NP. Implications of the Use
of Eukaryotic Translation Initiation Factor 5A (eIF5A)
for Prognosis and Treatment ofHepatocellular Carcinoma. Int J Hepatol, 2012.

Fatima S, Lee NP, Tsang FH, Kolligs FT, Ng IOL, Poon RTP, Fan ST, Luk JM. Dickkopf 4 (DKK4)
acts on Wnt/β-catenin pathway via influencing β-catenin in hepatocellular
carcinoma. Oncogene, 20;31(38):4233-4244 (2012).

Fatima S, Lee NP, Luk JM. Dickkopfs (DKKs) and Wnt/β-catenin signalling in liver cancer. World
Journal of Clinical Oncology, 2(8):311-325 (2011).

Tung KK, Mak KM, Fatima S, Lo CL, Heng Z, Zhang C, Dai H, Poon RTP, Yuen MF, Lai CL, Li J,
Luk JM, Ng IOL. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1
levels in human hepatocellular carcinoma. Liver International, 31(10):1494-1504 (2011).

Hu MY, Lam CT, Liu KD, Xu MZ, Fatima S, Su YC, Tsang FH, Chen J, Pang JZ, Win LX, Luk
JM. Proteomic identification of a monoclonal antibody recognizing Caveolin-1 in hepatocellular
carcinoma with metastatic potential. Protein Peptide Letters, 16(5):479-485 (2009).

Lu WJ, Lee NP, Fatima S, Luk JM. Heat shock proteins and cancer: signaling pathways, tumor
markers and molecular targets in liver malignancy. Protein Peptide Letters, 16(5):508-516
(2009).

Tang WK, Chui CH, Fatima S, Kok SHL, Pak KC, Ou TM, Hui KS, Wong MM, Wong J, Law S,
Tsao SW, Lam KY, Beh PHL, Srivastava G, Ho KP, Chan ASC, Tang JCO. Inhibitory effects
of Gleditsia sinensis fruit extract on telomerase activity and oncogenic expression in human
esophageal squamous cell carcinoma. International Journal of Molecular Medicine,
19(6):953-960 (2007).

Tang WK, Chui CH, Fatima S, Kok SHL, Pak KC, Ou TM, Hui KS, Wong MM, Wong J, Law S,
Tsao SW, Lam KY, Beh PSL, Srivastava G, Chan ASC, Ho KP, Tang JCO. Oncogenic properties
of a novel gene (JK-1) located in chromosome 5p and its overexpression in human esophageal
squamous cell carcinoma. International Journal of Molecular Medicine, 19(6):915-923 (2007).

Fatima S, Chui CH, Tang WK, Hui KS, Au HW, Li WY, Wong MM, Cheung F, Tsao SW, Wong J,
Law S, Srivastava G, Ho KP, Chan ASC, and Tang JCO. Transforming capacity of two novel
genes JS-1 and JS-2 located in chromosome 5p and their overexpression in human esophageal
squamous cell carcinoma. International Journal of Molecular Medicine, 17(1), 159-170 (2006).

Chui CH, Cheng GYM, Ke B, Lau FY, Wong RSM, Kok SHL, Fatima S, Cheung F, Cheng CH,
Chan ASC, Tang JCO. Growth inhibitory potential of effective microorganism fermentation extract
(EM-X) on cancer cells. International Journal of Molecular Medicine, 14(5), 925-929 (2004).

Chui CH, Tang JCO, Lau FY, Teo ITN, Yau MYC, Wong RSM, Cheng GYM, Ho SKW, Leung
TWT, Hui KS, Wong MM, Fatima S, Cheng CH, Cheung F, Tan WQ, Chow LMC, Guo DA, Chan
ASC. Gleditsia sinensis fruit extract induced growth inhibition involves basic fibroblast growth
factor and nitric oxide. International Journal of Molecular Medicine, 13(1), 169-173 (2004).